You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The BD MAX Check-Points CPO assay detects common carbapenemase-producing organisms in less than 2.5 hours.
The FDA said it observed a number of violations of federal law related to the company's Vacutainer blood collection tubes during an inspection.
The investment bank noted that Hologic could be the "biggest beneficiary from tax reform" in its coverage with a potential 8 percent benefit to earnings per share.
The Federal Trade Commission said today that Becton Dickinson and CR Bard have agreed to divest two medical device product lines to settle its complaint that the proposed $24-billion acquisition would negatively impact competition.
The results reflected the divesture of the firm's respiratory solutions business. The firm beat the consensus Wall Street estimates on the top and bottom lines.
Becton Dickinson and Euroclone aim to develop and commercialize the molecular assays for launch outside the US in 2018, and in the US at a later date.